Deferoxamine may enhance 5-aminolevulinic acid-based fluorescence in glioma surgery

被引：0
作者：
Yano, Hirohito [1 ]
Shinoda, Jun [2 ]
Iwama, Toru [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Neurosurg, 1-1 Yanagido, Gifu 5011194, Japan
[2] Kizawa Mem Hosp, Dept Neurosurg, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Japan
来源：
TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷
关键词：
CANCER STEM-CELLS; GLIOBLASTOMA-MULTIFORME; IRON CHELATION; RESECTION; OVERLOAD;
D O I：
10.21037/tcr.2017.08.06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1088 / S1090
页数：3
相关论文
共 15 条
  • [1] Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
    Aydinok, Yesim
    Kattamis, Antonis
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Origa, Raffaella
    Elalfy, Mohsen
    Kilinc, Yurdanur
    Perrotta, Silverio
    Karakas, Zeynep
    Viprakasit, Vip
    Habr, Dany
    Constantinovici, Niculae
    Shen, Junwu
    Porter, John B.
    [J]. BLOOD, 2015, 125 (25) : 3868 - 3877
  • [2] Exploring the role of cancer stem cells in radioresistance
    Baumann, Michael
    Krause, Mechthild
    Hill, Richard
    [J]. NATURE REVIEWS CANCER, 2008, 8 (07) : 545 - 554
  • [3] Iron overload disorders: Treatment options for patients refractory to or intolerant of phlebotomy
    Bring, Penny
    Partovi, Nilufar
    Ford, Jo-Ann E.
    Yoshida, Eric M.
    [J]. PHARMACOTHERAPY, 2008, 28 (03): : 331 - 342
  • [4] Tumour stem cells and drug resistance
    Dean, M
    Fojo, T
    Bates, S
    [J]. NATURE REVIEWS CANCER, 2005, 5 (04) : 275 - 284
  • [5] New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma
    Hide, Takuichiro
    Makino, Keishi
    Nakamura, Hideo
    Yano, Shigetoshi
    Anai, Shigeo
    Takezaki, Tatsuya
    Kuroda, Jun-ichiro
    Shinojima, Naoki
    Ueda, Yutaka
    Kuratsu, Jun-ichi
    [J]. NEUROLOGIA MEDICO-CHIRURGICA, 2013, 53 (11) : 764 - 772
  • [6] Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma
    Ishida, Joji
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Otani, Yoshihiro
    Onishi, Manabu
    Fujii, Kentaro
    Shimazu, Yosuke
    Oka, Tetsuo
    Shimizu, Toshihiko
    Date, Isao
    [J]. BRAIN TUMOR PATHOLOGY, 2015, 32 (04) : 245 - 252
  • [7] Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study
    Miwa, K
    Shinoda, J
    Yano, H
    Okumura, A
    Iwama, T
    Nakashima, T
    Sakai, N
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (10) : 1457 - 1462
  • [8] Heme oxygenase-1: unleashing the protective properties of heme
    Otterbein, LE
    Soares, MP
    Yamashita, K
    Bach, FH
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (08) : 449 - 455
  • [9] An extent of resection threshold for newly diagnosed glioblastomas
    Sanai, Nader
    Polley, Mei-Yin
    McDermott, Michael W.
    Parsa, Andrew T.
    Berger, Mitchel S.
    [J]. JOURNAL OF NEUROSURGERY, 2011, 115 (01) : 3 - 8
  • [10] Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
    Stummer, W
    Pichlmeier, U
    Meinel, T
    Wiestler, OD
    Zanella, F
    Hans-Jurgen, R
    [J]. LANCET ONCOLOGY, 2006, 7 (05) : 392 - 401
12